Samsung SGH-C225NBATMB - Manual (Page 139)

Appendix C: Consumer Update on Wireless Phones
139
The National Institutes of Health participates in some
interagency working group activities, as well.
FDA shares regulatory responsibilities for wireless phones with
the Federal Communications Commission (FCC). All phones that
are sold in the United States must comply with FCC safety
guidelines that limit RF exposure. FCC relies on FDA and other
health agencies for safety questions about wireless phones.
FCC also regulates the base stations that the wireless phone
networks rely upon. While these base stations operate at higher
power than do the wireless phones themselves, the RF
exposures that people get from these base stations are typically
thousands of times lower than those they can get from wireless
phones. Base stations are thus not the primary subject of the
safety questions discussed in this document.
4. What is FDA doing to find out more about the possible health
effects of wireless phone RF?
FDA is working with the U.S. National Toxicology Program and
with groups of investigators around the world to ensure that
high priority animal studies are conducted to address important
questions about the effects of exposure to radio frequency
energy (RF).
FDA has been a leading participant in the World Health
Organization International Electromagnetic Fields (EMF) Project
since its inception in 1996. An influential result of this work has
been the development of a detailed agenda of research needs
that has driven the establishment of new research programs
around the world. The Project has also helped develop a series
of public information documents on EMF issues.
FDA and the Cellular Telecommunications & Internet Association
(CTIA) have a formal Cooperative Research and Development
Agreement (CRADA) to do research on wireless phone safety.
FDA provides the scientific oversight, obtaining input from
experts in government, industry, and academic organizations.
CTIA-funded research is conducted through contracts to